The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancerMengmeng Song, Hanping Shi, Tong Liu et al.|Journal of Cachexia Sarcopenia and Muscle|2022Cited by 170
Inflammatory burden as a prognostic biomarker for cancerHailun Xie, Hanping Shi, Guo‐Tian Ruan et al.|Clinical Nutrition|2022Cited by 152
Systematic evaluation of cancer risk associated with rs2292832 in miR-149 and rs895819 in miR-27a: a comprehensive and updated meta-analysisYajing Feng, Shuli Cui, Fujiao Duan et al.|Oncotarget|2016Cited by 27
Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancerHailun Xie, Hanping Shi, Guo‐Tian Ruan et al.|Journal of Cachexia Sarcopenia and Muscle|2022Cited by 25
Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective studyHailun Xie, Hanping Shi, Guo‐Tian Ruan et al.|Inflammation Research|2022Cited by 21